Specialty enzymes market size will reach USD 4,565 million in 2030


VANCOUVER, BC, April 20, 2022 /PRNewswire/ — Specialty Enzyme Market Size Reached $4,565 million in 2021 and is expected to register a significantly rapid revenue CAGR over the forecast period, according to the latest analysis from Emergen Research. Rise in demand for non-harmful biocatalysts in pharmaceuticals and diagnostics has driven market revenue growth. The demand for specialty enzymes is increasing dramatically due to the growing application of enzymes in the pharmaceutical industry.


The advancement of tools to optimize pharmaceutical production and quality concerns among people have increased the use of specialized enzymes. The health and nutrition field of the enzyme industry is growing at a much faster rate, mainly due to the discovery of new applications such as obesity management, immunity development, health cardiovascular, anti-allergic applications, etc. Moreover, the same enzymes can be used in other industries, thus broadening the horizons of several major players. Factors such as the multifunctional advantages of specialized enzymes in various applications and technological innovations aimed at reducing the consumption of chemical catalysts are contributing to the revenue growth of the specialized enzymes market.

Request a free sample (to understand the full structure of this report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/519


Although specialized enzyme technologies are performed by several researchers, there is an overabundance of skilled technicians in areas where the technology is used in real world applications. One of the challenges in this field is the lack of sufficiently trained manpower to work with advanced gene expression technologies. Several tools and techniques used for the production of enzymes are mainly made by batch fermentation and laser extended for a continuous process, this requires advanced practical knowledge so that the tests can be carried out accurately.

Growth projections:

The global specialty enzymes market is expected to register a CAGR of 7.0% during the forecast period and revenue is expected to increase by $4,565 million in 2021 for $8,392.57 million in 2030. Rising demand for non-harmful biological catalysts in the pharmaceutical and diagnostic sector is driving the market revenue growth.

COVID-19 impact analysis:

The COVID-19 pandemic is expected to have a positive impact on the specialty enzymes market. In response to COVID-19, there has been a shift in medical priorities in healthcare facilities, with treating COVID-19 patients being the top priority. This has impacted the specialty enzymes market. Specialized enzymes provide an important platform to bridge the gap between auto-injectors and in-clinic care.

Browse Full Report Description + Research Methodology + Table of Contents + [email protected] https://www.emergenresearch.com/industry-report/specialty-enzymes-market

Current trends and innovations:

Advances in biotechnology have enabled the use of standardized products, thanks to the production of microbial enzymes. Fungal amylase exhibits medium thermos capacity, operating at temperatures between 58°C and 78°C. Due to its characteristic, it is inactivated before complete starch gelatinization, then its higher activity occurs on the damaged starch. The bakery industry has started to ask for innovative solutions to improve the benefits generated by the use of amylases.

Geographical perspectives:

North America The specialty enzymes market revenue is expected to grow at a significantly robust CAGR during the forecast period owing to technological advancements and development of innovative and successful products in this region, which have made enzymes available for a wide range of applications. ‘apps.

Strategic initiatives:

Major companies in the market report include Novozymes, Kerry, Inc., Chr. Hansen Holding A/S, Dupont De Nemours, Inc., Associate British Foods Plc, Specialty Enzymes & Probiotics., AST Enzymes, Sanofi, Amano Enzyme, Amgen Inc., Roche Holding, Codexis, Dyadic International, Thermo Fisher Scientific, Biocatalysts, and Merck KGaA.

  • In August 2021The United States Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients 1 year of age and older with late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person’s ability to move and breathe

Emergen Research is offering a limited time discount (grab a discounted copy now) @ https://www.emergenresearch.com/request-discount/519

Emergen Research has segmented Global Specialty Enzymes on the basis of Source, Type, Form, Application, End User and Region:

  • Source Outlook (Revenue, USD Million; 2019-2030)
    • Microorganisms
    • Plants
    • Animals
  • Type Outlook (Revenue, USD Million; 2019-2030)
    • Carbohydrases
      • Amylases
      • Cellulase
      • Other
    • Proteases
    • Lipases
    • Polymerases and nucleases
    • Other enzymes
  • Form Outlook (Revenue, USD Million; 2019-2030)
  • Application Outlook (Revenue, USD Million; 2019-2030)
    • Diagnostic applications
      • Clinical
      • Chemistry
      • Immunoassay
      • Molecular
      • Diagnostic
      • Other
      • Diagnostic
      • Apps
    • Pharmaceutical applications
      • Infectious diseases
      • Oncology
      • Diabetes
      • Neurology
      • Other
    • Food and beverage applications
    • Cosmetic applications
    • Other Apps
  • End User Outlook (Revenue, USD Million; 2019-2030)
    • Pharmaceutical industries
    • Diagnostic centers
    • food industries
    • Cosmetic industries
    • Other end users

Custom requirements can be requested for this report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/519

  • Regional Outlook (Revenue, USD Million; 2019-2030)
    • North America
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • South Korea
      • Australia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • United Arab Emirates
      • Saudi Arabia
      • Africa
      • Rest of MEA

Looking to buy reports in the bundle [Schedule a Call with An Analyst]@ https://www.emergenresearch.com/call-schedule/519

Read the latest reports published by Emergen Research:

Decentralized Finance Platforms Market Size, Share, Trends, By Component (Blockchain Technology, Decentralized Applications (dApps), Smart Contracts), By Application (Asset Tokenization, Compliance & Identity, Marketplaces & Liquidity) and By Region , forecast until 2028.

DNA Methylation Market, By Technology (Bisulfite DNA Modification, Others), By Application (DNA Sequencing, Others), By End-Use (Biotechnology Industry, Others), By Product ( enzymes, reagents, kits, others) and by region at 2030.

Orthopedic Diagnostic Devices Market Size, Share, Trends, By Product (X-ray, Fluoroscopy, Doppler Ultrasound Systems, Others), By Type (Stand-Alone and Point-of-Care), by Age Group, by Application, by User final and by region Forecast until 2030.

Microbial Bioremediation Market, By Pollutants (Organic Pollutants & Inorganic Pollutants), By Organism, By Type, By Technology, By Application, By End-Use, And By Region to 2030.

Omega 3 PUFA Market by Type (Docosahexaenoic Acid)[DHA]Eicosapentaenoic acid [EPA]Alpha-Linolenic Acid [ALA] and others), by source [Marine, Plant]by application and by region until 2028.

Flexible Organic Light Emitting Diodes Market By Technology (Passive Matrix OLED (PMOLED), Active Matrix OLED (AMOLED)), By Type Of Flexibility (Curved Display, Bendable Display), By Application, By End-Use, And By Region 2030.

Biobetters Market by Drug Class (Erythropoietin Biobetters, Insulin Biobetters), by Application (Cancer, Diabetes, Renal, Neurodegenerative), by Route of Administration (Subcutaneous, Oral), by Distribution Channel and by region, forecasts until 2030.

About Emergen Research

Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including health, touchpoints, chemicals, types and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Emergen Research has a strong base of experienced analysts from a variety of areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.

Contact us:

Eric Lee
Corporate Sales Specialist
Emerging research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for more information: https://www.emergenresearch.com/insights
Discover our personalized intelligence services | Growth Consulting Services
Press release available @ https://www.emergenresearch.com/press-release/global-specialty-enzymes-market

SOURCE Emerging research


Comments are closed.